MedTrace Logo

CArdiac cT in the Treatment of Acute CHest Pain 2 - Myocardial CT Perfusion

NCT02014311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2022-12-12

No results posted yet for this study

Summary

The aim of this study is to assess whether the clinical management of patients with recent acute-onset chest pain without acute coronary syndrome may be optimized by a combined coronary CT angiography (CTA) + CT myocardial perfusion (CTP) guided, rapid diagnostic strategy as compared to CTA alone. CT diagnostic evaluation and potential referral for invasive testing will be performed within 2 weeks after hospital discharge.

The following main hypothesis will be tested:

\- Combined assessment of coronary anatomy and myocardial perfusion using 320 MDCT results in a safe and optimized, cost-effective invasive treatment strategy

Conditions

Interventions

PROCEDURE

CTA+CTP guided treatment strategy

CTA+CTP guided treatment strategy

PROCEDURE

CTA guided treatment strategy

CTA guided treatment strategy

Sponsors & Collaborators

  • Copenhagen University Hospital, Hvidovre

    collaborator OTHER

  • Amager Hospital

    collaborator OTHER

  • Bispebjerg Hospital

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Glostrup University Hospital, Copenhagen

    collaborator OTHER

  • University Hospital, Gentofte, Copenhagen

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Klaus F Kofoed, MD, DmSc · Department of Cardiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-03-31
Completion
2022-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014311 on ClinicalTrials.gov